Lupin 2024

Clostridium difficile infection

CutisPharma grant to boost C. difficile awareness

CutisPharma grant to boost C. difficile awareness

WILMINGTON, Mass. — CutisPharma plans to award an unrestricted grant to the C Diff Foundation to further support its efforts to raise awareness of Clostridium difficile infection (C. difficile). A serious gastrointestinal infection, C. difficile — also known as C diff. — typically affects people who are on antibiotic therapy and/or have experienced a long-term hospitalization or

PP_1170x120_10-25-21